https://www.selleckchem.com/pr....oducts/Dasatinib.htm
https://www.selleckchem.com/pr....oducts/Dasatinib.htm
Fragment-Derived Discerning Inhibitors regarding Dual-Specificity Kinases DYRK1A and DYRK1B. INTRODUCTION The characteristics, prognostic factors, and management of duodenal neuroendocrine neoplasms (dNEN) are ill-defined given their rarity. Whether non-surgical management could be appropriate in good-prognosis non-metastatic dNEN, as for pancreatic NEN (pNEN), is unknown. We aimed to describe the management and prognosis of non-metastatic dNEN patients. METHODS All consecutive
Like
Comment
Share
